Corpus overview


MeSH Disease

Human Phenotype


gender (1)


There are no seroprevalence terms in the subcorpus

    displaying 1 - 1 records in total 1
    records per page

    TAE Combined with Microwave Ablation in the Treatment of Rare Giant Hepatic Hemangioma HP Hepatic Hemangioma MESHD:Case Report and Literature Review

    Authors: Yi-fu Feng; Xin-yi Chen; Jing-gang Mo; Hai-ling Wu; Jian-yu Zhou; Chong Jin; Hao Jiang; Wang Kun-Peng

    doi:10.21203/ Date: 2020-07-14 Source: ResearchSquare

    Background: hepatic hemangioma HP hepatic hemangioma MESHD is the most common benign tumor MESHD of the liver. However, patients with large hemangiomas HP hemangiomas MESHD that cause compression symptoms or that are at risk of rupture MESHD may need further intervention. It is necessary to explore additional minimally invasive and personalized treatment options.Case presentation: A 47-year-old female TRANS was diagnosed with right hepatic hemangioma MESHD hepatic hemangioma HP for more than 10 years. Abdominal contrast-enhanced CT and CEUS revealed that there was a large hemangioma HP hemangioma MESHD in the right liver, with a size of approximately 95x97x117 mm. Due to the patient's refusal of surgical treatment, hepatic artery embolization MESHD was performed in the first stage, then after 25 days of liver protection treatment, the liver function indexes decreased to normal levels. Then, B-ultrasound-guided microwave ablation of the giant hepatic hemangioma HP hepatic hemangioma MESHD was performed. Ten days after the surgery, hepatobiliary ultrasonography showed that the hemangioma HP hemangioma MESHD of the right liver was smaller than the previous size (the volume was reduced by approximately 30%). Then the patient was discharged from the hospital, and CT suggested that the hepatic hemangioma HP hepatic hemangioma MESHD is significantly smaller two months after discharge. Because of COVID-19, the patient's CT examination was delayed.Conclusions: TAE combined with microwave ablation is a safe and effective minimally invasive treatment for hepatic hemangioma HP hepatic hemangioma MESHD.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.



MeSH Disease
Human Phenotype

Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.